Capital Raising Simplified
Capital Raising Process: Structured for Risk Isolation and Investor Advantage
01
Phase 1: Acquisition Cell Formation
Each investment opportunity is established as a distinct Protected Cell within our Gibraltar PCC, legally segregating assets and liabilities to shield investors from cross-cell risks.
02
Phase 2: Targeted Capital Raise
Capital is raised exclusively from accredited and institutional investors for the specific Cell, ensuring that funds are dedicated solely to the designated acquisition without exposure to other projects.
03
Phase 3: Ongoing Asset Management and Reporting
Active management of each Cell’s assets is paired with transparent, regular reporting to investors, maintaining clear oversight and protecting investor interests throughout the investment lifecycle.
Capital Raising Process Overview
Our capital raising approach leverages the Gibraltar Protected Cell Company structure to isolate risks and safeguard investor capital for each acquisition.
Segregated Investment Cells
Risk Isolation by Design
Targeted Capital Allocation
Dedicated Investor Benefits
Transparent Deal Structuring
Legal Segregation of Assets
Capital Raising Process: Risk Isolation and Investor Benefits
Our capital raising approach centers on creating legally segregated Cells for each acquisition, ensuring investor capital is protected and risks are confined to individual projects. This structure allows investors to participate in targeted opportunities without exposure to liabilities from other Cells, enhancing portfolio security and clarity.
How does the Protected Cell Company structure safeguard my investment?
Each acquisition is housed within its own Cell, legally separated from others. This means liabilities and risks are isolated, preventing any financial impact from one Cell affecting another. Investors’ capital is ring-fenced, providing clear protection and transparency.What are the key stages in your capital raising process?
We begin by identifying acquisition targets and establishing dedicated Cells. Capital is then raised exclusively for each Cell from accredited investors. Following capital deployment, ongoing management and reporting ensure investors remain informed and risks are actively monitored.How do you manage risk across multiple investments?
Risk is managed by isolating each investment within its own Cell, preventing cross-contamination of liabilities. This segregation allows tailored risk assessment and mitigation strategies per acquisition, maintaining overall portfolio stability and investor confidence.What benefits do investors gain from this model?
Investors benefit from capital protection through legal segregation, targeted exposure to specific assets, and transparent reporting. The structure supports tax efficiency and limits downside risk, making it suitable for sophisticated investors seeking controlled, diversified opportunities.